动态混合模块驱动的NK细胞刺激和释放用于瘤免疫治疗
Deyan Jiao1, Min Hao2, Renhui Sun1
1Key Laboratory for Experimental Teratology of Ministry of Education and Department of Immunology, Cheeloo Medical College, Shandong University, Jinan 250000, China.
Nano letters
|April 19, 2024
概括
这项研究引入了一种可注射的水凝与酸纳米带,以改善自然杀手 (NK) 细胞治疗固体瘤. 这种新生物材料增强了NK细胞的保留和功能,提高了抗瘤功效.
科学领域:
- 生物材料科学 生物材料科学
- 免疫治疗是一种免疫疗法.
- 纳米技术纳米技术
背景情况:
- 自然杀手 (NK) 细胞在采用瘤免疫疗法方面表现有前途.
- 在固体瘤中NK细胞的治疗疗效目前有限.
研究的目的:
- 开发一种混合注射水凝和酸 (HAp) 纳米带系统,用于控制NK细胞的输送.
- 在固体瘤中增强NK细胞的治疗效果.
主要方法:
- 制造一个HAp-nanobelt修饰的奇托桑热敏水凝.
- 具有agonistic抗体 (NKG2D,4-1BB) 和细胞因子 (IL-2,IL-21) 的HAp纳米带的功能化.
- 在体内评估NK细胞保留,功能和抗瘤功效.
主要成果:
- 混合水凝系统显著改善了NK细胞在体内保留超过20天的时间.
- 与对照组相比,NK细胞功能增强了一倍以上.
- 该生物材料复合体保护了NK细胞,并提高了整体抗瘤功效.
结论:
- 可注射水凝和HAp纳米带系统代表了增强基于NK细胞的固体瘤免疫疗法的有希望的策略.
- 这种方法改善了NK细胞的生存,功能和瘤微环境中的保留.
- 创建一个短暂的炎症位可能有助于预防切除瘤中的癌症复发.
更多相关视频
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
01:27Cytotoxic T Cells-mediated Immune Response
904
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904